Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) improved during the last several trading days. AZN’s current Value Trend Rating is B and the prior Rating was C. Details supporting this higher rating are included in our next report.
Recent Price Action
On 6/21/24, Astrazeneca PLC (NASDAQ: AZN) stock rose modestly by 0.4%, closing at $78.88. NORMAL trading volume accompanied the advance. The stock has been strong relative to the market over the last nine months but has declined -1.5% during the last week.
Current PriceTarget Research Rating
AZN is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Astrazeneca has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Astrazeneca has a neutral Power Rating of 54 but a good Appreciation Score of 81, producing the Positive Value Trend Rating.
Be the first to comment